Foundayo for maintenance: keeping weight off, long term

Last reviewed: 23 August 2026

Maintenance is a phase, not an afterthought

Obesity is treated as a long-term condition, and GLP-1 medicines manage the biology of appetite rather than permanently resetting it. That has an uncomfortable implication people are rarely told upfront: for many, reaching a goal weight is not the end of treatment but the beginning of a different phase of it, in the same way that blood pressure controlled by medication generally stays controlled only while the medication continues.

Framing it that way early makes the whole journey easier. The question is not "when do I stop?" but "what does the sustainable long-term version of this look like for me?"

Why Foundayo suits the maintenance role

Three practical reasons, and one evidential one.

• The evidence: ATTAIN-MAINTAIN specifically tested the maintenance scenario, with people moving off injectable tirzepatide or semaglutide onto daily orforglipron and largely holding their loss.² That is a rare thing to have actual trial data for.
• Simplicity for the long haul: a daily tablet with no food rules, no fridge and no needles is far easier to sustain across years than a weekly injection with a cold chain.³
• Travel and life: maintenance spans holidays, house moves, hospital stays and busy periods. Room-temperature tablets survive all of it; see our storage and travel guides.
• Likely cost: tablets are generally cheaper to produce and distribute than injectables, and cost is the single most common reason people abandon long-term treatment. UK pricing is pending on our price lists.

Maintenance dosing

There is no single maintenance dose. Some people stay at the dose that got them to goal; others find a lower step holds their weight steady with fewer side effects and lower cost. Because the ladder runs through six strengths from 0.8 mg to 17.2 mg, there is room to find the lowest effective level rather than defaulting to the maximum.¹ That is a prescriber decision, made with monitoring, and our dose steps guide explains what each strength does.

The habits that carry the weight

Medication makes maintenance easier; it does not do it alone. The people who hold their results tend to have built the following while treatment was making it easy, and kept them afterwards:

• Protein at every meal, to protect the muscle that keeps your metabolic rate up. Detail in our nutrition guide.
• Resistance exercise twice a week, for the same reason. Muscle lost during rapid weight loss makes regain easier later.
• Consistent daily movement, which also helps the constipation that long-term GLP-1 users report most.
• Weekly weighing with a tripwire: decide in advance the number at which you act, so a 3 kg drift gets caught instead of becoming a 12 kg one.
• Steady hydration, since thirst stays quietened for as long as you are on treatment. See our hydration guide.

What long-term treatment involves

Expect regular reviews rather than an indefinite repeat prescription on autopilot. A reasonable service checks in on your weight trajectory, side effects, general health and whether the dose still suits you, and Foundayo is newly authorised in the UK, so prescribers will also be watching emerging safety data and any MHRA updates.⁴ If your provider shows no interest in reviewing you at all, that is a quality signal worth weighing, and our verification standards explain what a credible service looks like.

If you do want to stop

Plenty of people do, whether for cost, side effects, or simply because they want to try. That is a legitimate choice and it deserves a plan rather than an abrupt halt: our stopping guide covers the honest picture on regain, tapering conversations and what to do if weight starts returning. If cost is the driver, price the maintenance dose and compare providers before quitting, because a cheaper provider or a lower maintenance dose often solves the actual problem.